Pharmaceuticals Insights- Page 4 of 4

Reducing waste with lean delivery in facility design and construction

Applying a lean delivery approach to the design and construction of new facilities can reduce waste, lower costs and improve speed to market.

How to incorporate highly potent drug products into your facility

There are many benefits to adding highly potent drug products to your portfolio, including increasing demand and generating potentially higher profit margins. Making the decision to incorporate highly potent drug products into your manufacturing facility can be a challenging process.

A large chiller outside, which could be made more efficient with an ice storage system

How biopharma facilities can use ice in a glycol chiller system

Ice storage, coupled with a glycol chiller, can provide benefits that other options can’t.

Oral solid dose tablets on a continuous manufacturing line

Continuous OSD manufacturing—a technology update

Continuous oral solid dosage manufacturing is a transformational processing platform that is here today and is here to stay. Although the industry is working on harmonization and some level of standardization of the platforms, continuous manufacturing is not a one-size-fits all offering.

Closing the deal: Understanding when to close your process

When to close your pharmaceutical process

Too often, the term “closed process” is thrown around without an understanding of the salient issues. Pharmaceutical process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.

Can’t hack it? Why pharma should heed the growing threats to cyber security

Cybersecurity considerations for pharmaceutical companies

Who would want to hack a programmable logic controller? Is cybersecurity really that important for pharma companies?

Continuous OSD manufacturing and patient impact

FDA approved oral solid dosage (OSD) products are improving, changing and enhancing lives, via the use of a continuous manufacturing platform.

Passing through the barrier

Over the past decade, aseptic filling isolators have improved patient safety by use of barriers to isolate the point of filling from personnel. This industry-wide movement creates opportunities to further increase patient safety by minimizing viable and nonviable risks to the aseptic fill.

To outsource or not to outsource? That is the question: How to ensure your CMO stacks up

How to choose a contract manufacturing organization

The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.

Building a thoughtful manufacturing supply chain

In the past 5 years, the biopharmaceutical industry has seen unprecedented change. Precipitated by the need to support a global client base with products that are more targeted, efficacious and cost-effective, the challenge to have a robust manufacturing supply chain is more crucial than ever to a company’s survival.